慢性完全闭塞病变介入治疗临床研究进展

doi:10.16138/j.1673-6087.2021.03.002

摘要/Abstract

关键词: 慢性完全闭塞, 经皮冠状动脉介入治疗, 心肌梗死, 慢性冠脉综合征

中图分类号:

R541

陆浩, 葛雷. 慢性完全闭塞病变介入治疗临床研究进展[J]. 内科理论与实践, 2021, 16(03): 145-150.

参考文献 30

[1]	Luo C, Huang M, Li J, et al. Predictors of interventional success of antegrade PCI for CTO[J]. JACC Cardiovasc Imaging, 2015, 8(7): 804-813. doi: 10.1016/j.jcmg.2015.04.008 URL
[2]	Grantham JA, Marso SP, Spertus J, et al. Chronic total occlusion angioplasty in the United States[J]. JACC Cardiovasc Interv, 2009, 2(6): 479-786. doi: 10.1016/j.jcin.2009.02.008 URL
[3]	Christofferson RD, Lehmann KG, Martin GV, et al. Effect of chronic total coronary occlusion on treatment strategy[J]. Am J Cardiol, 2005, 95(9): 1088-1091. pmid: 15842978
[4]	Kandzari DE, Kini AS, Karmpaliotis D, et al. Safety and effectiveness of everolimus-eluting stents in chronic total coronary occlusion revascularization[J]. JACC Cardiovasc Interv, 2015, 8(6): 761-769. doi: 10.1016/j.jcin.2014.12.238 URL
[5]	Ge JB, Ge L, Zhang B, et al. Active greeting technique: a mother-and-child catheter based technique to facilitate retrograde wire externalization in recanalization of coronary chronic total occlusion[J]. Sci Bull, 2018, 63: 1565-1569. doi: 10.1016/j.scib.2018.09.015 URL
[6]	Brilakis ES, Grantham JA, Rinfret S, et al. A percutaneous treatment algorithm for crossing coronary chronic total occlusions[J]. JACC Cardiovasc Interv, 2012, 5(4): 367-379. doi: 10.1016/j.jcin.2012.02.006 URL
[7]	Harding SA, Wu EB, Lo S, et al. A new algorithm for crossing chronic total occlusions from the Asia Pacific Chronic Total Occlusion Club[J]. JACC Cardiovasc Interv, 2017, 10(21): 2135-2143. doi: 10.1016/j.jcin.2017.06.071 URL
[8]	中国冠状动脉慢性闭塞病变介入治疗俱乐部. 中国冠状动脉慢性完全闭塞病变介入治疗推荐路径[J]. 中国介入心脏病学杂志, 2018, 26(3): 121-124.
[9]	Christopoulos G, Karmpaliotis D, Alaswad K, et al. Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry[J]. Int J Cardiol, 2015, 198: 222-228. doi: 10.1016/j.ijcard.2015.06.093 pmid: 26189193
[10]	Claessen BE, Dangas GD, Weisz G, et al. Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial[J]. Eur Heart J, 2012, 33(6): 768-775. doi: 10.1093/eurheartj/ehr471 pmid: 22240495
[11]	O’Connor SA, Garot P, Sanguineti F, et al. Meta-analysis of the impact on mortality of noninfarct-related artery coronary chronic total occlusion in patients presenting with ST-segment elevation myocardial infarction[J]. Am J Cardiol, 2015, 116(1): 8-14. doi: 10.1016/j.amjcard.2015.03.031 URL
[12]	Bataille Y, Déry JP, Larose é, et al. Deadly association of cardiogenic shock and chronic total occlusion in acute ST-elevation myocardial infarction[J]. Am Heart J, 2012, 164(4): 509-515. doi: 10.1016/j.ahj.2012.07.008 pmid: 23067908
[13]	Henriques JP, Hoebers LP, Råmunddal T, et al. Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: the EXPLORE trial[J]. J Am Coll Cardiol, 2016, 68(15): 1622-1632. doi: S0735-1097(16)34795-7 pmid: 27712774
[14]	Tong J, Yu Q, Li C, et al. Successful revascularization of noninfarct related artery with chronic total occlusion among acute myocardial infarction patients: a systematic review and meta-analysis[J]. Medicine (Baltimore), 2018, 97(3): e9655. doi: 10.1097/MD.0000000000009655 URL
[15]	Christakopoulos GE, Christopoulos G, Carlino M, et al. Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions[J]. Am J Cardiol, 2015, 115(10): 1367-1375. doi: 10.1016/j.amjcard.2015.02.038 pmid: 25784515
[16]	Lee SW, Lee PH, Ahn JM, et al. Randomized trial evaluating percutaneous coronary intervention for the treatment of chronic total occlusion[J]. Circulation, 2019, 139(14): 1674-1683. doi: 10.1161/CIRCULATIONAHA.118.031313 URL
[17]	Werner GS, Martin-Yuste V, Hildick-Smith D, et al. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions[J]. Eur Heart J, 2018, 39(26): 2484-2493. doi: 10.1093/eurheartj/ehy220 URL
[18]	Stone PH, Gratsiansky NA, Blokhin A, et al. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA(Efficacy of Ranolazine in Chronic Angina) trial[J]. J Am Coll Cardiol, 2006, 48(3): 566-575. doi: 10.1016/j.jacc.2006.05.044 URL
[19]	Sapontis J, Salisbury AC, Yeh RW, et al. Early procedural and health status outcomes after chronic total occlusion angioplasty[J]. JACC Cardiovasc Interv, 2017, 10(15): 1523-1534. doi: 10.1016/j.jcin.2017.05.065 URL
[20]	Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation(COURAGE) trial nuclear substudy[J]. Circulation, 2008, 117(10): 1283-1291. doi: 10.1161/CIRCULATIONAHA.107.743963 URL
[21]	Sachdeva R, Agrawal M, Flynn SE, et al. The myocardium supplied by a chronic total occlusion is a persistently ischemic zone[J]. Catheter Cardiovasc Interv, 2014, 83(1): 9-16. doi: 10.1002/ccd.25001 URL
[22]	Bucciarelli-Ducci C, Auger D, Di Mario C, et al. CMR guidance for recanalization of coronary chronic total occlusion[J]. JACC Cardiovasc Imaging, 2016, 9(5):547-556. doi: 10.1016/j.jcmg.2015.10.025 pmid: 27085432
[23]	Jang WJ, Yang JH, Choi SH, et al. Long-term survival benefit of revascularization compared with medical therapy in patients with coronary chronic total occlusion and well-developed collateral circulation[J]. JACC Cardiovasc Interv, 2015, 8(2): 271-279. doi: 10.1016/j.jcin.2014.10.010 URL
[24]	Aboul-Enein F, Kar S, Hayes SW, et al. Influence of angiographic collateral circulation on myocardial perfusion in patients with chronic total occlusion of a single coronary artery and no prior myocardial infarction[J]. J Nucl Med, 2014, 45(6): 950-955.
[25]	Dong W, Li J, Mi H, et al. Relationship between collateral circulation and myocardial viability of ¹⁸F-FDG PET/CT subtended by chronic total occluded coronary arteries[J]. Ann Nucl Med, 2018, 32(3):197-205. doi: 10.1007/s12149-018-1234-3 pmid: 29380138
[26]	Choi JH, Chang SA, Choi JO, et al. Frequency of myocardial infarction and its relationship to angiographic collateral flow in territories supplied by chronically occluded coronary arteries[J]. Circulation, 2013, 127(6): 703-709. doi: 10.1161/CIRCULATIONAHA.112.092353 URL
[27]	Małek ŁA, Śpiewak M, Kłopotowski M, et al. Combined analysis of myocardial function, viability, and stress perfusion in patients with chronic total occlusion in relation to collateral flow[J]. Kardiol Pol, 2015, 73(10): 909-915. doi: 10.5603/KP.a2015.0083 URL
[28]	Shokry KA, Farag EM, Salem AMH, et al. Relationship between quality of coronary collateral and myocardial viability in chronic total occlusion: a magnetic resonance 1.study[J]. Int J Cardiovasc Imaging, 2021, 37(2): 623-631. doi: 10.1007/s10554-020-02027-9 URL
[29]	Schumacher SP, Everaars H, Stuijfzand WJ, et al. Coronary collaterals and myocardial viability in patients with chronic total occlusion[J]. EuroIntervention, 2020, 16(6): e453-e461. doi: 10.4244/EIJ-D-19-01006 pmid: 32122823
[30]	Ybarra LF, Rinfret S, Brilakis ES, et al. Definitions and clinical trial design principles for coronary artery chronic total occlusion therapies: CTO-ARC consensus recommendations[J]. Circulation, 2021, 143(5): 479-500. doi: 10.1161/CIRCULATIONAHA.120.046754 pmid: 33523728

慢性完全闭塞病变介入治疗临床研究进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 30

相关文章 15

编辑推荐

Metrics

本文评价

[1]	周慈航, 涂丁元, 白元. 超速起搏救治急性心肌梗死合并电风暴1例[J]. 内科理论与实践, 2022, 17(04): 337-338.
[2]	席锐, 范骎, 王芳, 陶蓉, 顾刚. D-二聚体联合半胱氨酸蛋白酶抑制剂C预测急性心肌梗死患者PCI术后的主要不良心血管事件[J]. 内科理论与实践, 2022, 17(03): 227-232.
[3]	胡健, 杨震坤, 闫小响, 杜润, 丁风华, 刘俊. 经皮冠状动脉介入术和冠状动脉旁路移植术对80岁以上左前支慢性闭塞患者的疗效比较[J]. 内科理论与实践, 2022, 17(01): 70-72.
[4]	胡健, 杨震坤, 闫小响, 倪钧, 丁风华. 冠状动脉慢性闭塞病变内膜下支架植入术的临床疗效[J]. 内科理论与实践, 2021, 16(04): 230-233.
[5]	翟光耀, 冯逊逊, 郭倩云, 周玉杰. 准分子激光冠状动脉斑块消融术在复杂冠状动脉病变介入治疗中的应用与发展[J]. 内科理论与实践, 2021, 16(03): 141-144.
[6]	王墨扬, 陈阳, 叶蕴青, 张洪亮, 吴永健. 主动脉瓣狭窄合并冠心病患者的经导管主动脉瓣置换联合介入治疗[J]. 内科理论与实践, 2021, 16(03): 151-154.
[7]	钱杰. 血管内超声指导冠状动脉左主干介入治疗[J]. 内科理论与实践, 2021, 16(03): 155-160.
[8]	刘晓丽, 马晓腾. CYP2C19基因型与冠心病精准抗血小板治疗[J]. 内科理论与实践, 2021, 16(03): 161-166.
[9]	丁思霄, 熊婧, 张毅, 赵逸凡, 张恒彬, 徐亚伟. 胸痛中心时间管理系统的临床应用[J]. 内科理论与实践, 2021, 16(03): 202-204.
[10]	陈航炜, 戴秋艳. 冠心病的精准治疗[J]. 内科理论与实践, 2021, 16(03): 212-216.
[11]	王春花, 祁爽, 王敏. 原发性醛固酮增多症合并无痛性心肌梗死一例报告[J]. 诊断学理论与实践, 2020, 19(05): 528-530.
[12]	罗晓颖, 许燕, 张建盛, 吴立群, 戚文航. N端脑钠肽前体预测首次急性心肌梗死后新发心房颤动的价值研究[J]. 诊断学理论与实践, 2020, 19(03): 303-307.
[13]	杨鹏, 邢冰, 孙伟, 武宗寅,. 右胸V_4R导联ST段抬高在急性前壁ST段抬高型心肌梗死的临床价值分析[J]. 内科理论与实践, 2019, 14(02): 94-98.
[14]	于洋, 吉律, 王海嵘, 费爱华,. 血清降钙素原水平对急性心肌梗死患者预后的判断价值[J]. 内科理论与实践, 2017, 12(06): 391-394.
[15]	陈媛媛, 王燕萍, 吴丽苹, 陈亚芬, 杨克, 刘艳. 卵泡抑素样蛋白1及其在心血管疾病中的作用研究进展[J]. 诊断学理论与实践, 2017, 16(06): 659-663.